Clinical Trial

Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder

Recruiting
View on ClinicalTrials.gov →
Summary
The researchers will test whether cognitively enhanced transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex can reduce craving in inpatients with cocaine use disorder. Neuroimaging before and after stimulation will establish the neural correlates of recovery and allow predictions of outcomes, which will be assessed throughout the study and one month after its completion. Results could pave the way towards development of a new self-administered intervention to reduce craving when it is needed the most, enhancing recovery real-time and in the natural environment in people with cocaine addiction as generalizable to other drugs of abuse and other disorders of self-control.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-01.
Trial Details
NCT Number NCT07318480
Lead Sponsor Icahn School of Medicine at Mount Sinai
Collaborators: National Institute on Drug Abuse (NIDA), Soterix Medical
Conditions Cocaine Use Disorder, Cocaine Dependence, Substance Use Disorder (SUD)
Enrollment 120 participants
Start Date 2026-02-25
Primary Completion 2030-02 (estimated)
Study Completion 2030-02 (estimated)
Updated on ClinicalTrials.gov 2026-03-03